The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| VMD | -7.48% | -10.39% | -2.17% | +314% |
| S&P | +16.49% | +84.25% | +12.99% | +151% |
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.
It's time for investors to adapt to a new normal.
They've been outperforming the S&P 500 by wide margins this year.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $71.91M | 24.0% |
| Gross Profit | $40.95M | 20.4% |
| Gross Margin | 56.94% | -1.7% |
| Market Cap | $263.36M | -7.5% |
| Market Cap / Employee | $0.22M | 0.0% |
| Employees | 1.2K | 18.4% |
| Net Income | $3.60M | -7.8% |
| EBITDA | $14.50M | 25.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $11.12M | -2.0% |
| Accounts Receivable | $27.41M | 1.3% |
| Inventory | 5.3 | 22.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $22.00M | 290.3% |
| Short Term Debt | $2.70M | 66.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 7.32% | 0.8% |
| Return On Invested Capital | 13.58% | -1.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $10.73M | 515.7% |
| Operating Free Cash Flow | $18.37M | 44.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 29.20 | 24.40 | 20.39 | 20.54 | -28.02% |
| Price to Book | 2.50 | 2.17 | 2.03 | 1.92 | -15.73% |
| Price to Sales | 1.48 | 1.30 | 1.18 | 1.08 | -22.63% |
| Price to Tangible Book Value | 3.43 | 2.92 | 2.71 | 2.54 | -18.99% |
| Price to Free Cash Flow TTM | 32.49 | 85.11 | 252.66 | 51.06 | 13.06% |
| Enterprise Value to EBITDA | 27.65 | 36.92 | 23.91 | 20.02 | -21.84% |
| Free Cash Flow Yield | 3.1% | 1.2% | 0.4% | 2.0% | -11.55% |
| Return on Equity | 9.2% | 9.8% | 10.8% | 10.5% | 18.03% |
| Total Debt | $6.87M | $6.76M | $6.89M | $24.70M | 240.29% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
